In vitro and in vivo evaluation in healthy human volunteers of floating riboflavin minitablets

Journal of Drug Delivery Science and Technology

Volumn 16, Issue 5, 2006, Pages 351-356

  Goole, J ^a   Hamdani, J ^a   Vanderbist, F ^b   Amighi, K ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Laboratoires SMB SA   (Belgium)

Author keywords

Floating minitablets; In vivo study; Melt granulation; Riboflavin; Sustained release; Urinary excretion

Indexed keywords

BICARBONATE; CALCIUM CARBONATE; GLYCEROL PALMITOSTEARATE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; RIBOFLAVIN; TARTARIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG MANUFACTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; SUSTAINED RELEASE PREPARATION; TABLET; URINALYSIS; URINARY EXCRETION;

EID: 33749491451     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(06)50064-4     Document Type: Article

References (26)

1. SOPPIMATH K., KULKARNI A.R., RUDZINSKI W.E., AMINABHAVI T.M. - Microspheres as floating drug-delivery systems to increase gastric retention of drugs. - Drug Metabolism Review, 33, 149-160, 2001.
2. OTH M., FRANZ M., TIMMERMANS J., MOËS A.J. - The bilayer floating capsule: a stomach-direct drug delivery system for misoprostol. - Pharm. Res., 9, 298-302, 1992.
3. PATEL V.R., AMIJI M.M. - Preparation and characterization of freeze-dried chitosan-poly(ethyleneoxide) hydrogels for site specific antibiotic delivery in the stomach. - Pharm. Res., 13, 588-593, 1996.
4. WHITEHEAD L., COLLET J.H., FELL J.T. - Amoxycillin release from a floating dosage form based on alginates. - Int. J. Pharm., 210, 45-49, 2000.
5. HOFFMAN A., STEPENSKY D., LAVY E., EYAL S., KLAUSNER E., FRIEDMAN M. - Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. - Int. J. Pharm., 277, 141-153, 2004.
6. ROUGE N., BURI P., DOELKER E. - Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. - Int. J. Pharm., 136, 117-139, 1996.
7. SETH P.R., TOSSOUNIAN J. - Sustained release tablet formulations. - US Patent 4, 140, 755, 1979.
8. SETH P.R., TOSSOUNIAN J. - The hydrodynamically balanced system HBSTM: a novel drug delivery system for oral use. - Drug Dev. Ind. Pharm., 10, 313-339, 1984.
9. MOËS A.J. - Recherche et développement de formes orales à libération prolongée. - J. Pharm. Belg., 44, 60-70, 1989.
10. SINGH B., KIM K.H. - Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. - J. Controlled Release, 63, 235-259, 2000.
11. SATO Y., KAWASHIMA Y., TAKEUCHI H., YAMAMOTO H. - In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. - Int. J. Pharm., 275, 97-107, 2004.
12. JUSKO W.J., LEVY G. - Absorption metabolism and excretion of riboflavin-5'-phosphate in man. - J. Pharm. Sci., 56, 58-62, 1967.
13. LEVY G., HEWIT R.R. - Evidence in man for different specialized intestinal transport mechanisms for riboflavin and thiamine. - Am. Clin. Nutr., 24, 401-404, 1971.
14. INGANI H.M., TIMMERMANS J., MOES A.J. - Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. - Int. J. Pharm., 35, 157-164, 1987.
15. KLAUSNER E.A., LAVY E., FRIEDMAN M., HOFFMAN A. - Expandable gastroretentive dosage forms. - J. Controlled Release, 90, 143-162, 2003.
16. SATO Y., KAWASHIMA Y., TAKEUCHI H., YAMAMOTO H. - In vivo evaluation of riboflavin-containing microballoonsforfloating controlled drug delivery system in healthy human volunteers. - J. Controlled. Release, 93, 39-47, 2003.
17. AHMAD I., FASIHULLAH Q., NOOR A., ANSARI I.A., ALI Q.N.M. - Photolysis of riboflavin in aqueous solution: a kinetic study. - Int. J. Pharm., 280, 199-208, 2004.
18. AHMAD I., FASIHULLAH Q., VAID F.H.M. - A study of simultaneous photolysis and photoaddition reactions of riboflavin in aqueous solution. - J. Photochemical and Photobiology B: Biology, 75, 13-20, 2004.
19. HAMDANI J., MOËS A.J., AMIGHI K. - Development and evaluation of prolonged release pellets obtained by melt pelletization process. - Int. J. Pharm., 245, 167-177, 2002.
20. TIMMERMANS J., MOËS A.J. - Measuring the resultant-weight of an immersed test material: I. Validation of an apparatus and a method dedicated to pharmaceutical applications. - Acta Pharm. Technol., 36, 171-175, 1990.
21. SHAH V.P., TSONG Y., SATHE P., LIU J.-P. - In vitro dissolution profile comparison -Statistics and analysis of similar factor, f2. - Pharmaceutical Research, 15, 889-896, 1998.
22. BURCH H.B., BESSEY O.A., LOWRY O.H. - Fluorimetric measurements of riboflavin and its natural derivatives in small quantities of blood, serums and cells. - J. Biol. Chem., 175, 457-470, 1948.
23. Merck Index, Twelfth Edition, Merck & Co., Inc., USA, 1996.
24. DAVIS S.S., HARDY J.G., TAYLOR M.J., WHALLEZ D.R., WILSON C.C. - The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). - Int. J. Pharm., 21, 331-340, 1984.
25. DAVIS S.S., KHOSLA R., WILSON C.G., WASHINGTON N. - Gastrointestinal transit of a controlled-release pellet formulation of tiaprofenic acid and the effect of food. - Int. J. Pharm., 35, 253-258, 1987.
26. MOËS A.J. - Gastroretentive dosage forms. - Critical Review in Therapeutic Drug Carrier Systems, 10, 143-195, 1993.